We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+22.83%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$117B
AUM Growth
+$14.6B
(+14%)
Cap. Flow
-$5.2B
Cap. Flow
% of AUM
-4.46%
Top 10 Holdings %
Top 10 Hldgs %
33.15%
Holding
314
New
18
Increased
56
Reduced
195
Closed
8
Avg Time Held
4.4
years
Top 10 Avg Time Held
4.9
years
Top 20 Avg Time Held
4.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$392M |
| 2 |
T-Mobile US
TMUS
|
+$236M |
| 3 |
Carrier Global
CARR
|
+$88.3M |
| 4 |
Otis Worldwide
OTIS
|
+$78M |
| 5 |
Baidu
BIDU
|
+$77.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$554M |
| 2 |
Eli Lilly
LLY
|
+$354M |
| 3 |
Microsoft
MSFT
|
+$327M |
| 4 |
Texas Instruments
TXN
|
+$225M |
| 5 |
Discover Financial Services
DFS
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.01% |
| 2 | Healthcare | 30.74% |
| 3 | Industrials | 10.56% |
| 4 | Consumer Discretionary | 9.5% |
| 5 | Financials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Honeywell
HON
$66.7B
| $36.2M | 0.03% |
265,918
-815,740
| -75% | -$108M |
2013 Q2
28 quarters
|
|
177
Cerence
CRNC
$415M
| $35.9M | 0.03% |
878,405
-6,787
| -0.8% | -$195K |
2019 Q4
2 quarters
|
|
|
NUVA
178
DELISTED
NuVasive, Inc.
NUVA
| $34.9M | 0.03% |
627,600
-55,300
| -8% | -$3.2M |
2013 Q2
28 quarters
|
|
|
ARNA
179
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $34.9M | 0.03% |
554,570
-25,430
| -4% | -$1.4M |
2018 Q3
7 quarters
|
|
180
Las Vegas Sands
LVS
$24.8B
| $34.7M | 0.03% |
762,800
-14,900
| -2% | -$700K |
2013 Q2
28 quarters
|
|
181
Ryanair
RYAAY
$27B
| $33.5M | 0.03% |
1,262,750
-14,750
| -1% | -$373K |
2017 Q4
10 quarters
|
|
182
Axon Enterprise
AXON
$33.9B
| $33.5M | 0.03% |
341,000
-51,000
| -13% | -$4.12M |
2016 Q2
16 quarters
|
|
183
DELISTED
Amicus Therapeutics
FOLD
| $32.1M | 0.03% |
2,130,000
-131,000
| -6% | -$1.6M |
2019 Q3
3 quarters
|
|
184
Zentalis Pharmaceuticals
ZNTL
$212M
| $31.7M | 0.03% |
+659,950
| New | +$25.3M |
2020 Q2
0 quarters
|
|
|
NBL
185
DELISTED
Noble Energy, Inc.
NBL
| $31M | 0.03% |
3,462,647
+32,000
| +0.9% | +$286K |
2013 Q2
28 quarters
|
|
186
DELISTED
Southwestern Energy Company
SWN
| $30.7M | 0.03% |
12,001,125
-348,300
| -3% | -$994K |
2013 Q2
28 quarters
|
|
187
Pentair
PNR
$8.53B
| $30.5M | 0.03% |
801,800
-4,110
| -0.5% | -$145K |
2013 Q2
28 quarters
|
|
|
TPTX
188
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $29.4M | 0.03% |
+455,000
| New | +$26.2M |
2020 Q2
0 quarters
|
|
189
VF Corp
VFC
$6.68B
| $28.7M | 0.02% |
471,700
-43,300
| -8% | -$2.52M |
2013 Q2
28 quarters
|
|
190
IMAX
IMAX
$2.83B
| $28.5M | 0.02% |
2,543,200
-11,100
| -0.4% | -$130K |
2016 Q1
17 quarters
|
|
191
NN Inc
NNBR
$327M
| $28.4M | 0.02% |
5,987,700
-227,600
| -4% | -$795K |
2014 Q1
25 quarters
|
|
192
McDonald's
MCD
$172B
| $28M | 0.02% |
152,000
| – | – |
2016 Q1
17 quarters
|
|
|
PRSP
193
DELISTED
Perspecta Inc. Common Stock
PRSP
| $28M | 0.02% |
1,204,721
-9,100
| -0.7% | -$198K |
2018 Q2
8 quarters
|
|
194
Norfolk Southern
NSC
$73B
| $27.8M | 0.02% |
158,100
-44,200
| -22% | -$7.49M |
2013 Q2
28 quarters
|
|
195
Altria Group
MO
$123B
| $27.6M | 0.02% |
702,424
-60,600
| -8% | -$2.36M |
2017 Q2
12 quarters
|
|
|
PFNX
196
DELISTED
Pfenex Inc.
PFNX
| $27.1M | 0.02% |
3,244,100
-19,700
| -0.6% | -$147K |
2015 Q2
20 quarters
|
|
197
Dell
DELL
$301B
| $26.2M | 0.02% |
941,265
-2,456
| -0.3% | -$55.2K |
2016 Q3
15 quarters
|
|
198
Western Digital
WDC
$133B
| $26.1M | 0.02% |
783,093
+138,611
| +22% | +$4.49M |
2016 Q2
16 quarters
|
|
199
Standard BioTools
LAB
$258M
| $24.1M | 0.02% |
6,003,443
-174,600
| -3% | -$608K |
2013 Q2
28 quarters
|
|
200
GSK
GSK
$98.2B
| $22.8M | 0.02% |
447,440
| – | – |
2013 Q2
28 quarters
|
|
Similar funds
Primecap Management's Q2 2020 Portfolio in Review
As of Q2 2020, Primecap Management held 314 positions worth $117B, up 14% from $102B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Primecap Management withdrew a net $5.2B in Q2 2020, closing 8 positions and reducing 195 holdings. Its most notable exit was Sprint Corporation, an estimated $215M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Primecap Management opened a new position in ASML worth $460M.
- Primecap Management's largest Q2 2020 buy was ASML: 1,249,987 shares worth $460M.
- Primecap Management added most to T-Mobile US in Q2 2020, an estimated $236M increase.
- Primecap Management's biggest Q2 2020 reduction was Adobe, cutting an estimated $554M.
- Primecap Management fully exited Sprint Corporation in Q2 2020, selling an estimated $215M.
- Primecap Management's ten largest holdings make up 33% of its $117B portfolio in Q2 2020.
- Primecap Management opened 18 new positions and closed 8 in Q2 2020.
- Primecap Management's portfolio value rose 14% quarter-over-quarter to $117B.
Based on Primecap Management's 13F filing for Q2 2020, filed 13 Aug 2020.